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The sequence of the HIV Nef protein has no significant homology to other proteins in the SwissProt database, and experimental data concerning 
its function are sparse and contradictory. Using a novel protein sequence comparison method, we find similarities between different Nef sequences 
and the a chain of human MHC class I proteins. The possible biologica impli~tions of this f&ding are discussed. 
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1. INTRODUCTION 
The function of the Nef-protein of HIV, one of the 
nine gene products of the virus, is still a mystery. While 
virus lacking the nef gene infects cultured cells and rep- 
licates in vitro, no aquired i~unode~ciency syndrome 
in monkeys seems to develop without Nef [l]. Besides 
the putative function as an element downregulating 
growth, which gave Nef its name (‘negative regulatory 
factor’) and which has been refuted-since [2,3], other 
functions for Nef have been suggested. In the literature, 
many ‘significant homologies’ between Nef sequences 
and other proteins in the database have been reported. 
For instance, Nef has been proposed to be related with 
MHC class II p-chains [4], with membrane-associated 
G-proteins [5], with scorpion neurotoxins [6], with leuc- 
ine zipper transcriptional activators [7], with superanti- 
gens [S], to name only few. The significance of those 
sequence relationships, however, appears to be based on 
the experience of the authors, but not on a quantitative 
estimation. It is obvious, for instance, that short align- 
ments need a higher residue identity to be considered as 
‘significant’. Recently, a database-derived significance 
threshold has been derived, which assesses the probabil- 
ity of structural (and possibly functional) homology be- 
tween two proteins as a function of the alignment length 
and the sequence identity. According to the significance 
threshold, a sequence identity of 25% in alignments of 
length 80 or more indicates structural homology of the 
aligned portions of the sequence; a higher sequence 
identity is needed to draw the same conclusion for a 
shorter alignment [9]. Unfortunately, we were not able 
to confirm the si~ifi~an~ of any relationship reported 
for Nef by searching Nef sequences against the Swiss- 
Prot protein sequence database [lo] with 28154 entries 
using the database-derived significance threshold. 
2. PROPSEARCH, A NEW PROTEIN SEQUENCE 
SEARCHING METHOD 
Conventional database searching tools compare the 
sequential order of amino acid residues between two 
sequences. We have developed another searching tool 
(PROPSEARCH), which instead compares the amino 
acid composition of two sequences while neglecting any 
sequential order of residues [l 11. This approach tries to 
avoid some of the di~culties of conventional sequence 
comparison, such as different connectivity of secondary 
structure elements in similar tertiary structures or com- 
pensatory point mutations (charge flips, hydrophobic 
flips) and represents an attempt o discover generic sim- 
ilarities between protein sequences not dependent on the 
precise order of residues, In PROPSEARCH, a se- 
quence is represented as a vector of 144 compositional 
properties (property vector), where properties are sim- 
ple values such as the content of single or paired amino 
acids. Two sequences are compared by calculating the 
euclidian distance between their respective property 
vectors. A database search is performed by comparing 
the properties of a query sequence with all sequences in 
the SwissProt database [9] and sorting distances, with 
the smallest distances indicating potential structural or 
functional similarities. A typical database search takes 
about 4 seconds on a common workstation. 
*Corresponding author. Fax: (49) (6221) 387 517. 
Prior to database searches, the weights for individual 
properties have been trained using a genetic algorithm 
and a selection of structurally distinct protein families 
as training set [l 11, resulting in a vector of 144 weights. 
This property search approach is in some cases capa- 
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ble of identifying protein pairs with similar structure, 
but without detectable sequence relationship. For in- 
stance, searching for yeast hexokinase-B, which is 
known to have the same overall structure as actin and 
some members of the Hsc70 heat shock protein family, 
but no sequence similarity [12], we found 25 actins and 
18 heat shock proteins among the first 200 hits. On the 
other hand, in some cases the program fails to detect 
known remote structural homologues and may report 
false positives. Therefore, the detected relationships 
merely represent hypotheses that need to be scrutinized 
by other means. 
3. RESULTS 
Applying the property search program to 26 HIV Nef 
sequences from the SwissProt database (sequences with 
an obvious deletion were not considered), the most 
abundant protein species found besides HIV Nef itself 
are 01 chains of the MHC class I proteins. HIV Nef 
sequences were from different isolates of HIV1 and 
HIV2 and are mutualy diverse among themselves, with 
a sequence identity between 27% and 98%. Class I se- 
quences were from ten different species with a sequence 
identity between 51% and 99%. 26 HIV Nef sequences 
find, on average, 24 HLA class I sequences among the 
first 200 hits. No other protein family shows compara- 
ble similarity to Nef with respect o amino acid proper- 
ties. 
For comparison, we did a property search using Nef 
sequences from SIV. The average distance between SIV 
Nef and the MHC class I family is greater: 12 Nef 
sequences from SIV find, on average, only 6 MHC class 
I d chains among the first 200 hits, and the MHC class 
I rx chain is not the most abundant protein family found 
by SIV Nef. 
4. DISCUSSION 
Viruses can ‘steal’ genes from their hosts and use 
them for their own purposes. Particularly, several im- 
portant immune system proteins are used by viruses to 
elude the immune response (for review, see [13]). No 
sequence similarity between Nef and HLA class I CI 
chains can be detected. Proteins can, however, exchange 
all amino acids and retain the structure. The globins, for 
instance, have diverged down to the level of random 
sequence identity (C 15%). The high mutation rate of 
retroviruses may have permitted a complete separation 
of the two protein families in sequence space. 
Nef as a MHC class I structural homolog might inter- 
fere with the assembly and/or transport of class I mole- 
cules. The downregulation of class I molecules by viral 
gene products as a defense mechanism against he hosts 
immunological attack is known from other viruses such 
as adenovi~s and human cytomegalovirus (HCMV). 
Adenovirus type 2 E3119K protein binds to class I mol- 
ecules forming a ternary complex and interferes with the 
transport to the celi surface [14]. The HCMV UL18 
gene product binds /I-Zmicroglobulin as a class I hom- 
ologue and suppresses the assembly of mature class I 
molecules [15]. Both strategies most likely reduce or 
suppress the presentation of viral peptides on the cell 
surface and hide the virus from the cytotoxic immune 
response. Even a temporary escape from the immune 
response may be advantageous. It may be enough to 
gain some hours in the race between virus and host 
defense to finish synthesis and assembly of viral pro- 
teins and to start release of virions. Nef is an early gene 
product and is not needed later in the life cycle of HIV 
The first Nef mRNA can be detected about 12 h after 
infection in H9 cells, virus production begins about 24 
h after infection [16]. A transient down modulation of 
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Fig. 1. Difference in amino acid content between HIV Nef and MHC class I sequences (A) and between HIV Nef and random sequences (B). (A) 
The amino acid content was compared between 26 HIV Nef sequences and 62 MHC class I sequences. (B) The amino acid content was compared 
between 26 HIV Nef sequences and 1000 sequences randomly selected from the SwissProt Database. Differences in amino acid content (in percent) 
were multiplied with the respective weights. This was done for all possible sequence pairs and averaged over the number of pairs. (Horizontal axis: 
amino acids, one letter code. Note that the weight for glutamic acid E was 0.0. Remember also that in a PROPSEARCHdatabase search the distance 
between two sequences is calculated using 144 properties, of which only 20 are shown here). 
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MHC class I molecules in another cell line, CEM-ES, 
beginning 18 h post-infection and reverting to normal 
level 24 h post-infection has been described [17], al- 
though this temporary down-modulation was not attri- 
buted to a specific viral gene product. 
The h~othesis is compatible with the finding that 
Nef is not important for infectivity in vitro, but for 
progression of AIDS in vivo [l], because there is no 
immune response in cell culture. 
The proposal is based on a novel method of sequence 
comparison that has yet to be established as a reliable 
tool, but the similarity between HIV Nef sequences and 
MHC class I cz chain sequences in terms of weighted 
amino acid residue and dipeptide-content is interesting 
enough to take a closer look by experiment: is there any 
antibody crossreactivity between Nef protein and MHC 
class I 01 chain molecules? Is the MHC class I display 
downregulated in Nef expressing cells? 
REFERENCES 
[l] Kestler, H.W., Ringler, D.J., Mori, K., Panicah, D.L., Sehgal, 
P.K., Daniel, M.D. and Desrosiers, R.C. (199l)Cell65,651-662. 
I21 
[31 
[41 
[51 
161 
I71 
PI 
[91 
WI 
II 11 
WI 
I131 
1141 
WI 
[161 
1171 
Kim, S., Ikeuchi, K., Byrn, R., Groopman, J. and Baltimore, D. 
(1989) Proc. Natl. Acad. Sci. USA 86, 95449548. 
Hammes, S.R., Dixon, E.P., Malim, M.H., Cullen, B.R. and 
Greene, W.C. (1989) Proc. Natl. Acad. Sci. USA 86,9549-9553. 
Vega, M.A., Guido, R. and Smith, T. (1990) Nature 345, 26. 
Guy, B., Riviere, Y., Dott, K., Regnault, A. and Kieny, M.P. 
(1990) Virology 176, 413425. 
Werner, T., et al. (1991) AIDS 5, 1301-1308. 
Samuel, K.P., Hodge, D.R., Chen, Y.M.A. and Papas, T.S. 
(1991) Aids Research and Human Retroviruses 7, 697-706. 
Haase, A.T., Jenkins, M.K., Peng, H. and Urdahl, K. (1992) 
Curr. Biol. 2, 130-132. 
Sander, C. and Schneider, R. (1991) Proteins 9, 5668. 
Bairoch, A. and Boeckmann, B. (1991) Nucleic Acids Res. 19, 
2247-2250. 
Hobohm, U. and Sander, C., manuscript in preparation 
Holmes, K.C., Sander, C. and Valet&a, A. (1993) Trends Cell 
Biol. 3, 53-59. 
Gooding, L.R. (1992) Cell 71, 5-7. 
Burger& H.-G. and Kvist, S. (1985) Cell 41, 987-997. 
Browne, H., Smith, G., Beck, S. and Minson, T. (1990) Nature 
347, 770-772. 
Kim, S., Byrn, R., Groopman, J. and Baltimore, D. (1989) J. 
Virol. 63, 370883713. 
Scheppler, J.A., Nicholson, J.K.A., Swan, D.C., Ahmed-Ansari, 
A. and ~cDouga1, S. (1989) J. Immunol. 143, 285882866. 
213 
